Abstract
Purpose
To investigate the potential involvement of fertility treatments and other conditions of becoming pregnant (infertility, getting pregnant on birth control, maternal history of fetal loss) and folic acid supplements in the etiology of childhood leukemia (CL).
Methods
The ESTELLE study included 747 cases of CL [636 cases of acute lymphoblastic leukemia (ALL) and 100 of acute myeloblastic leukemia (AML)] diagnosed in France in 2010–2011 and 1,421 population controls frequency-matched with the cases on age and gender. Data were obtained from structured telephone questionnaires administered to mothers. The odds ratios (OR) and their 95 % confidence intervals were estimated using unconditional regression models adjusted for potential confounders.
Results
CL was not associated with difficulty in becoming pregnant [OR 0.9 (0.7–1.2)], in vitro fertilisation [OR 0.6 (0.3–1.5)] or the use of any fertility treatment [OR 0.8 (0.5–1.1)] for the index pregnancy. CL was not significantly associated with becoming pregnant on contraception [OR 1.2 (0.8–1.8)], but a positive association was observed for third generation oral contraception [OR 4.3 (1.2–16.2)]; however, the result is based on small numbers. Folic acid supplementation during pregnancy was not associated with CL, but an inverse borderline association was observed for supplementation initiated in the 3 months preceding pregnancy [OR 0.7 (0.5–1.0)]. In addition, maternal histories of stillbirth and miscarriage were associated with ALL [OR 2.6 (1.1–5.9)] and AML [OR 1.8 (1.1–2.8)], respectively.
Conclusions
The findings do not suggest that infertility and fertility treatments are risk factors for CL. They suggest that maternal histories of stillbirth and miscarriage may be more frequent among mothers of CL cases and that folic acid supplementation during preconception may reduce the risk of CL.

Similar content being viewed by others
Abbreviations
- AL:
-
Acute leukemia
- ALL:
-
Acute lymphocytic leukemia
- AML:
-
Acute myeloblastic leukemia
- AI:
-
Artificial insemination
- ART:
-
Assisted reproductive technologies
- CL:
-
Childhood acute leukemia
- COCs:
-
Combined oral contraceptives
- CATI:
-
Computer-assisted telephone interviewing
- GIFT:
-
Gamete intrafallopian transfer
- ICSI:
-
Intracytoplasmic sperm injection
- IVF:
-
In vitro fertilization
- NRCH:
-
National Registry of Childhood Hematopoietic Malignancies
- NRST:
-
National Registry of Childhood Solid Tumors
- OR:
-
Odds ratios
- ZIFT:
-
Zygote intrafallopian transfer
References
Desandes E, Clavel J, Berger C et al (2004) Cancer incidence among children in France, 1990–1999. Pediatr Blood Cancer 43:749–757
Stiller CA (2004) Epidemiology and genetics of childhood cancer. Oncogene 23:6429–6444
Eden T (2010) Aetiology of childhood leukaemia. Cancer Treat Rev 36:286–297
Papaemmanuil E, Hosking FJ, Vijayakrishnan J et al (2009) Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 41:1006–1010
Trevino LR, Yang W, French D et al (2009) Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 41:1001–1005
Ellinghaus E, Stanulla M, Richter G et al (2012) Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia 26:902–909
Orsi L, Rudant J, Bonaventure A et al (2012) Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE). Leukemia 26:2561–2564
Rudant J, Amigou A, Orsi L et al (2013) Fertility treatments, congenital malformations, fetal loss, and childhood acute leukemia: the ESCALE study (SFCE). Pediatr Blood Cancer 60:301–308
Hargreave MJA, Deltour I, Brinton LA, Andersen KK, Kjaer SK (2013) Increased risk for cancer among offspring of women with fertility problems. Int J Cancer 133:1180–1186
Roman E, Ansell P, Bull D (1997) Leukaemia and non-Hodgkin’s lymphoma in children and young adults: are prenatal and neonatal factors important determinants of disease? Br J Cancer 76:406–415
Schuz J, Weihkopf T, Kaatsch P (2007) Medication use during pregnancy and the risk of childhood cancer in the offspring. Eur J Pediatr 166:433–441
Petridou ET, Sergentanis TN, Panagopoulou P et al (2012) In vitro fertilization and risk of childhood leukemia in Greece and Sweden. Pediatr Blood Cancer 58:930–936
Williams CL, Bunch KJ, Stiller CA et al (2013) Cancer risk among children born after assisted conception. N Engl J Med 369:1819–1827
Hargreave M, Jensen A, Toender A, Andersen KK, Kjaer SK (2013) Fertility treatment and childhood cancer risk: a systematic meta-analysis. Fertil Steril 100:150–161
Lightfoot T, Bunch K, Ansell P, Murphy M (2005) Ovulation induction, assisted conception and childhood cancer. Eur J Cancer 41:715–724 (discussion 25–6)
Wen W, Shu XO, Potter JD et al (2002) Parental medication use and risk of childhood acute lymphoblastic leukemia. Cancer 95:1786–1794
Shaw AK, Infante-Rivard C, Morrison HI (2004) Use of medication during pregnancy and risk of childhood leukemia (Canada). Cancer Causes Control 15:931–937
Pombo-de-Oliveira MS, Koifman S (2006) Infant acute leukemia and maternal exposures during pregnancy. Cancer Epidemiol Biomark Prev 15:2336–2341
Ou SX, Han D, Severson RK et al (2002) Birth characteristics, maternal reproductive history, hormone use during pregnancy, and risk of childhood acute lymphocytic leukemia by immunophenotype (United States). Cancer Causes Control 13:15–25
Hakim RB, Gray RH, Zacur H (1995) Infertility and early pregnancy loss. Am J Obstet Gynecol 172:1510–1517
Cnattingius S, Zack MM, Ekbom A et al (1995) Prenatal and neonatal risk factors for childhood lymphatic leukemia. J Natl Cancer Inst 87:908–914
Fajardo-Gutierrez A, Garduno-Espinosa J, Yamamoto-Kimura L et al (1993) Risk factors associated with the development of leukemia in children. Bol Med Hosp Infant Mex 50:248–257
Hassanzadeh J, Mohammadi R, Rajaeefard AR, Bordbar MR, Karimi M (2011) Maternal and prenatal risk factors for childhood leukemia in southern of Iran. Iran Red Crescent Med 13:398–403
Kaye SA, Robison LL, Smithson WA, Gunderson P, King FL, Neglia JP (1991) Maternal reproductive history and birth characteristics in childhood acute lymphoblastic leukemia. Cancer 68:1351–1355
Ma X, Metayer C, Does MB, Buffler PA (2005) Maternal pregnancy loss, birth characteristics, and childhood leukemia (United States). Cancer Causes Control 16:1075–1083
McKinney PA, Juszczak E, Findlay E, Smith K, Thomson CS (1999) Pre- and perinatal risk factors for childhood leukaemia and other malignancies: a Scottish case–control study. Br J Cancer 80:1844–1851
Murray L, McCarron P, Bailie K et al (2002) Association of early life factors and acute lymphoblastic leukaemia in childhood: historical cohort study. Br J Cancer 86:356–361
Perrillat F, Clavel J, Jaussent I et al (2002) Breast-feeding, fetal loss and childhood acute leukaemia. Eur J Pediatr 161:235–237
Podvin D, Kuehn CM, Mueller BA, Williams M (2006) Maternal and birth characteristics in relation to childhood leukaemia. Paediatr Perinat Epidemiol 20:312–322
Reynolds P, Von Behren J, Elkin EP (2002) Birth characteristics and leukemia in young children. Am J Epidemiol 155:603–613
Ross JA, Potter JD, Shu XO, Reaman GH, Lampkin B, Robison LL (1997) Evaluating the relationships among maternal reproductive history, birth characteristics, and infant leukemia: a report from the children’s cancer group. Ann Epidemiol 7:172–179
Schuz J, Kaatsch P, Kaletsch U, Meinert R, Michaelis J (1999) Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol 28:631–639
Shu XO, Gao YT, Brinton LA et al (1988) A population-based case–control study of childhood leukemia in Shanghai. Cancer 62:635–644
van Steensel-Moll HA, Valkenburg HA, Vandenbroucke JP, van Zanen GE (1985) Are maternal fertility problems related to childhood leukaemia? Int J Epidemiol 14:555–559
Yeazel MW, Buckley JD, Woods WG, Ruccione K, Robison LL (1995) History of maternal fetal loss and increased risk of childhood acute leukemia at an early age. Cancer 75:1718–1727
Zack M, Adami HO, Ericson A (1991) Maternal and perinatal risk factors for childhood leukemia. Cancer Res 51:3696–3701
Dockerty JD, Herbison P, Skegg DC, Elwood M (2007) Vitamin and mineral supplements in pregnancy and the risk of childhood acute lymphoblastic leukaemia: a case–control study. BMC Public Health 7:136
Milne E, Royle JA, Miller M et al (2010) Maternal folate and other vitamin supplementation during pregnancy and risk of acute lymphoblastic leukemia in the offspring. Int J Cancer 126:2690–2699
Thompson JR, Gerald PF, Willoughby ML, Armstrong BK (2001) Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case–control study. Lancet 358:1935–1940
Amigou A, Rudant J, Orsi L et al (2012) Folic acid supplementation, MTHFR and MTRR polymorphisms, and the risk of childhood leukemia: the ESCALE study (SFCE). Cancer Causes Control 23:1265–1277
Lacour B, Guyot-Goubin A, Guissou S, Bellec S, Desandes E, Clavel J (2010) Incidence of childhood cancer in France: national children cancer registries, 2000–2004. Eur J Cancer Prev 19:173–181
Clavel J, Goubin A, Auclerc MF et al (2004) Incidence of childhood leukaemia and non-Hodgkin’s lymphoma in France: National Registry of Childhood Leukaemia and Lymphoma, 1990–1999. Eur J Cancer Prev 13:97–103
Blondel B, Lelong N, Kermarrec M, Goffinet F (2012) Trends in perinatal health in France from 1995 to 2010. Results from the French National Perinatal Surveys. J Gynecol Obstet Biol Reprod 41:e1–e15
Rosenberg L, Coogan PF, Palmer JR (2006) Case–control surveillance. In: Strom BL, Kimmel SE (eds) Text book of pharmacoepidemiology, 4th edn. Wiley, Philadelphia, pp 137–149
Rookus MA, van Leeuwen FE (1996) Induced abortion and risk for breast cancer: reporting (recall) bias in a Dutch case–control study. J Natl Cancer Inst 88:1759–1764
Perrillat F, Clavel J, Auclerc MF et al (2002) Day-care, early common infections and childhood acute leukaemia: a multicentre French case–control study. Br J Cancer 86:1064–1069
Metayer C, Milne E, Dockerty JD et al. (In press) Maternal supplementation with folic acid and other vitamins and risk of leukemia in the offspring: a childhood leukemia international consortium study. Epidemiology
Acknowledgments
The authors are grateful to: Noureddine Balegroune, Sofiène Ben salha and the team of clinical research associates who contributed to the recruitment of the cases; Laure Faure and the staff of the French National Registry of Childhood Blood Malignancies, who contributed to case detection and verification; Christophe David and the team of interviewers (Institut IPSOS), who recruited the controls and interviewed the cases and controls. The authors would like to thank all of the Société Française de lutte contre les Cancers de l’Enfant et de l’Adolescent (SFCE) principal investigators: André Baruchel (Hôpital Saint-Louis/Hôpital Robert Debré, Paris), Claire Berger (Centre Hospitalier Universitaire, Saint-Etienne), Christophe Bergeron (Centre Léon Bérard, Lyon), Gerard Michel (Hôpital La Timone, Marseille), Yves Bertrand (Hôpital Debrousse, Lyon), Pascal Chastagner (Centre Hospitalier Universitaire, Nancy), Patrick Boutard (Centre Hospitalier Régional Universitaire, Caen), Gérard Couillault (Hôpital d’Enfants, Dijon), Christophe Piguet (Centre Hospitalier Régional Universitaire, Limoges), Anne-Sophie Defachelles (Centre Oscar Lambret, Lille), François Demeocq (Hôpital Hôtel-Dieu, Clermont-Ferrand), Alain Fischer (Hôpital des Enfants Malades, Paris), Virginie Gandemer (Centre Hospitalier Universitaire – Hôpital Sud, Rennes), Dominique Valteau-Couanet (Institut Gustave Roussy, Villejuif), Philippe Colombat (Centre Gatien de Clocheville, Tours), Frederic Millot (Centre Hospitalier Universitaire Jean Bernard, Poitiers), Guy Leverger (Hôpital Armand-Trousseau, Paris), Patrick Lutz (Hôpital de Hautepierre, Strasbourg), Nicolas Sirvent (Hôpital Arnaud de Villeneuve, Montpellier), Xavier Rialland (Hôpital Mère et Enfants, Nantes), Martine Münzer (American Memorial Hospital, Reims), Brigitte Nelken (Hôpital Jeanne de Flandre, Lille), François Doz (Institut Curie, Paris), Brigitte Pautard (Centre Hospitalier Universitaire, Amiens), Yves Perel (Hôpital Pellegrin Tripode, Bordeaux), Alain Pierre-Kahn (Hôpital Enfants Malades, Paris), Emmanuel Plouvier (Centre Hospitalier Régional, Besançon), Xavier Rialland (Centre Hospitalier Universitaire, Angers), Alain Robert (Hôpital des Enfants, Toulouse), Hervé Rubie (Hôpital des Enfants, Toulouse), Nicolas Sirvent (L’Archet, Nice), Marilyne Poiree (Fondation Lenval, Nice), Jean-Pierre Vannier (Hôpital Charles Nicolle, Rouen), Dominique Plantaz (Centre Hospitalier Universitaire, Grenoble), Philippe le moine (Hôpital Morvan, Brest) and Christian Sainte Rose (Centre Hospitalier Universitaire Necker, Paris). The authors would like also to thank all of the Lebanese university. This work was supported by grants from the Ligue Nationale Contre le Cancer (LNCC), the Agence Nationale de Sécurité Sanitaire de l’alimentation, de l’Environnement et du Travail (ANSES), the Institut National du Cancer (INCa) and the association Enfants et santé.
Conflict of interest
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ajrouche, R., Rudant, J., Orsi, L. et al. Maternal reproductive history, fertility treatments and folic acid supplementation in the risk of childhood acute leukemia: the ESTELLE Study. Cancer Causes Control 25, 1283–1293 (2014). https://doi.org/10.1007/s10552-014-0429-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-014-0429-8